Xponance

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-01
Total Holdings
1,445
Total Value
10340327523
Accession Number
0001085146-25-002511
Form Type
13F-HR
Manager Name
Xponance
Data Enrichment
99% identified
1,428 identified17 unidentified

Holdings

1,445 positions • $10.3B total value
Manager:
Search and click to pin securities to the top
Page 73 of 73
NEKTAR THERAPEUTICS
Shares:12.2K
Value:$8.3K
% of Portfolio:0.0% ($8.3K/$10.3B)
CHEGG, INC
Shares:10.0K
Value:$6.4K
% of Portfolio:0.0% ($6.4K/$10.3B)
Lyell Immunopharma, Inc.
Shares:11.3K
Value:$6.1K
% of Portfolio:0.0% ($6.1K/$10.3B)
Lineage Cell Therapeutics, Inc.
Shares:12.9K
Value:$5.8K
% of Portfolio:0.0% ($5.8K/$10.3B)
X4 Pharmaceuticals, Inc
Shares:11.0K
Value:$2.6K
% of Portfolio:0.0% ($2.6K/$10.3B)